PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.
Frequently asked questions
What sector does Pharmacom Biovet Inc (PHMB) operate in?
Pharmacom Biovet Inc belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Pharmacom Biovet Inc (PHMB) current stock price?
As of the latest data, Pharmacom Biovet Inc stock price is $0.00, with a previous close of $0.00.
Does Pharmacom Biovet Inc (PHMB) pay dividends?
No. Pharmacom Biovet Inc does not pay a dividend.
What is Pharmacom Biovet Inc (PHMB) beta (volatility) score?
Pharmacom Biovet Inc has a beta of 0.000, indicating lower volatility than the overall market.